Dr. Martin Fabry

Martin Fabry completed his bachelor’s degree in Molecular Biomedicine at the University of Bonn in 2014 and subsequently moved to the US as a visiting scientist at Cold Spring Harbor Laboratory (New York), where he worked on improving CRISPR/Cas9 technologies. In 2016, he obtained a master’s degree in Life and Medical Sciences with a focus on molecular mechanisms of immunity, before starting his PhD in Medical Sciences with Cancer Research UK at the University of Cambridge, where he studied genome organisation and stability.

After receiving his doctorate in 2020, Martin worked as a postdoctoral fellow in computational biology at the Gurdon Institute and the European Bioinformatics Institute (EBI) in Cambridge, focusing on stem cell development and the establishment of new technologies for stem cell differentiation.

Martin is a registered German and European Patent and Trademark Attorney, and became Managing Director of IP2 in early 2025.